Inozyme Pharma
BioTech/Drugs - Boston, MA, US
Inozyme Pharma Senior Management
Inozyme Pharma Details
We are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.
Website:
inozyme.com
Employees:
100 - 249
HQ:
857-330-4340
Location:
Boston, MA, US
Revenue:
10 - 20 Million
Inozyme Pharma Technologies
Email Providers
Outlook
CMS
WP Engine
Web Performance Monitoring
New Relic
Other
Microsoft Office 365
Hosting
Amazon AWS